AzTrials
AzTrials

Dental Caries in ChildrenPhase 1NCT05941429

Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride

A Phase 1 study testing Nano-Silver Fluoride and Silver diamine fluoride in people with Dental Caries in Children, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will be conducted to test the cariostatic effect of Nano Silver Fluoride in a comparison to Silver Diamine Fluoride in a group of preschool children. Read more about this study

Who is it for?
Ages 3 to 5 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries in Children
What is being tested?
Nano-Silver Fluoride and Silver diamine fluoride
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
1 siteEgypt
Study dates
7 Feb 2024to Dec 2024
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children aged from 3 to 5 years
  • clinical diagnosis of active dentinal caries in primary teeth
  • Co-operative participants and free of any systemic diseases

Who cannot join

  • Children whose parents refuse to sign consent
  • Primary teeth with pulp involvement, pain, mobility, abscess, sinus, fistula; or discoloration related to tooth non-vitality.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo university

    Giza

Other trials in Egypt

About this study

Official title: Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride in a Group of Preschool Children

This study will be conducted to test the cariostatic effect of Nano Silver Fluoride in a comparison to Silver Diamine Fluoride in a group of preschool children.

Read the detailed description

Silver Diamine Fluoride has offered a non-invasive and easily performed method to manage dental caries in very young children.Studies shows that SDF has been proven to arrest caries in cavitated lesions and to prevent caries in sound teeth as Fluoride is effective in enhancing the remineralization of dental hard tissue and silver ion acts as an antibacterial agent. However, It was found that silver causes staining to the dental tissues with a black discoloration, which can be considered to be a main drawback specifically, when it is used on anterior teeth. Nano-silver fluoride varnish preparation showed high efficacy in arresting caries progression in primary teeth without causing black discoloration to the tissues.Silver diamine fluoride (SDF) .

Benefits for patient:

  1. Non-invasive treatment leading to reduce patient anxiety and stress.
  2. No drilling and filling.
  3. Protects against further caries progression.

Benefits for the practitioner:

  1. Provide alternative treatment options.
  2. Pain-free procedure that facilitates child management and saves time.

Benefits for the community:

  1. Increasing overall oral health
  2. Provides more information by testing new material
  3. To provide better service quality.
Being tested
Nano-Silver Fluoride, Silver diamine fluoride

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nano-Silver FluorideDrug

    Also called NSF

    NSF is a varnish which has been introduced as experimental formulation . the laboratory synthesis of NSF was carried out in a nano techonolgy center .

  • Silver diamine fluorideDrug

    Also called SDF

    38% silver diamine fluoride

Study groups in NCT05941429
Study groupRoleWhat they receive
Silver Diamine FluorideActive comparator38% Silver Diamine Fluoride varnish 1. the affected tooth will be cleaned by a disposable micro-brush for 30 seconds and then will be dried using cotton gauze sponges. 2. No excavation will be done to the infected dentin tissue prior to the application of the agent. 3. Gum will be protected with petroleum jelly, and isolation will be achieved by using cotton rolls. 4. After isolation, a single drop SDF will be applied into the cavity by using a disposable micro-brush for at least two minutes. Then site of application will be covered with petroleum jelly. 5. Finally, parents will be instructed that children participating in the trial are not allowed to eat or drink for one hour after application of the agent
Receives: Drug: Silver diamine fluoride
Nano-Silver FluorideExperimentalNano-Silver fluoride varnish preparation 1. the affected tooth will be cleaned by a disposable micro-brush for 30 seconds and then will be dried using cotton gauze sponges. 2. No excavation will be done to the infected dentin tissue prior to the application of the agent. 3. Gum will be protected with petroleum jelly, and isolation will be achieved by using cotton rolls. 4. After isolation, a single drop NSF will be applied into the cavity by using a disposable micro-brush for at least two minutes. Then site of application will be covered with petroleum jelly. 5. Finally, parents will be instructed that children participating in the trial are not allowed to eat or drink for one hour after application of the agent
Receives: Drug: Nano-Silver Fluoride

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. caries lesion activity and severity assessment using Nyvad criteria

    visual and tactile assessment for caries lesion to evaluate the caries progression using Nyvad classification - score from 0 ( normal enamel translucency and texture ) to 9 (carie lesion with filling )

    Measured: baseline

  2. caries lesion activity and severity assessment using Nyvad criteria

    visual and tactile assessment for caries lesion to evaluate the caries progression using Nyvad classification - score from 0 ( normal enamel translucency and texture ) to 9 (carie lesion with filling )

    Measured: 3 weeks

  3. caries lesion activity and severity assessment using Nyvad criteria

    visual and tactile assessment for caries lesion to evaluate the caries progression using Nyvad classification - score from 0 ( normal enamel translucency and texture ) to 9 (carie lesion with filling )

    Measured: 6 months

Secondary outcomes (3)
  1. ICDAS II

    Detection and assessment of dental caries using ICDAS II - assessment done by photographs - score from 0 ( sound ) to 6 ( Extensive cavity with visible dentin )

    Measured: baseline

  2. ICDAS II

    Detection and assessment of dental caries using ICDAS II - assessment done by photographs - score from 0 ( sound ) to 6 ( Extensive cavity with visible dentin )

    Measured: 3 weeks

  3. ICDAS II

    Detection and assessment of dental caries using ICDAS II - assessment done by photographs - score from 0 ( sound ) to 6 ( Extensive cavity with visible dentin )

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2023
  2. Study start7 Feb 2024
  3. Primary completionNov 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
78 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05941429
Sponsor's protocol ID
14422021493714
Status last verified
Oct 2024
First submitted
21 Jun 2023
Last updated
16 Oct 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Nano-Silver Fluoride and Silver diamine fluoride in people with Dental Caries in Children, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

caries lesion activity and severity assessment using Nyvad criteria (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in